Bulletin

Investor Alert

Alexion Pharmaceuticals Inc.

NAS: ALXN

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders

/marketstate/country/us

Alexion Pharmaceuticals Inc.

After Hours

--Quotes are delayed by 20 min

Mar 5, 2021, 5:29 p.m.

ALXN

/zigman2/quotes/206262068/composite

150.10

Change

0.00 0.00%

Volume

Volume 89,322

Quotes are delayed by 20 min

/zigman2/quotes/206262068/composite

Previous close

$ 148.46

$ 150.10

Change

+1.64 +1.10%

Day low

Day high

$148.18

$150.56

52 week low

52 week high

$72.67

$162.60

Income Statement Balance Sheet Cash Flow Statement

Annual Financials for Alexion Pharmaceuticals Inc.

View Ratios

Assets

Fiscal year is January-December. All values USD millions.	2016	2017	2018	2019	2020
Cash & Short Term Investments	1.29B	1.47B	1.56B	2.79B	3.07B
Cash Only	966M	584.4M	1.37B	2.72B	3.03B
Short-Term Investments	327M	889.7M	198.3M	64M	34.9M
Cash & Short Term Investments Growth	-	14.01%	6.09%	78.24%	10.12%
Cash & ST Investments / Total Assets	9.76%	10.85%	11.22%	15.89%	16.96%
Total Accounts Receivable	650M	726.5M	922.3M	1.24B	1.41B
Accounts Receivables, Net	650M	726.5M	922.3M	1.24B	1.41B
Accounts Receivables, Gross	650M	726.5M	922.3M	1.24B	1.41B
Bad Debt/Doubtful Accounts	-	-	-	-	-
Other Receivables	-	-	-	-	-
Accounts Receivable Growth	-	11.77%	26.95%	34.79%	13.36%
Accounts Receivable Turnover	4.63	4.85	4.48	3.99	4.30
Inventories	375M	460.4M	472.5M	627.6M	775.7M
Finished Goods	215M	307.1M	350.7M	405.6M	-
Work in Progress	143M	148.6M	90.4M	180.8M	-
Raw Materials	17M	4.7M	31.4M	41.2M	-
Progress Payments & Other	-	-	-	-	-
Other Current Assets	260M	292.9M	426.4M	418.3M	578.6M
Miscellaneous Current Assets	260M	292.9M	426.4M	418.3M	578.6M
Total Current Assets	2.58B	2.95B	3.39B	5.08B	5.83B

	2016	2017	2018	2019	2020
Net Property, Plant & Equipment	1.04B	1.33B	1.47B	1.37B	1.46B
Property, Plant & Equipment - Gross	1.23B	1.49B	1.69B	1.59B	1.74B
Buildings	450M	427.9M	520.1M	208.7M	216.7M
Land & Improvements	10M	9.6M	9.6M	9.6M	9.6M
Computer Software and Equipment	123M	141.5M	144.8M	155.1M	171.9M
Other Property, Plant & Equipment	25M	23.8M	27.5M	23.4M	24.9M
Accumulated Depreciation	193M	160.3M	219.3M	220.9M	274.3M
Total Investments and Advances	69M	16.6M	300,000	79.9M	143.3M
Other Long-Term Investments	69M	16.6M	300,000	79.9M	143.3M
Long-Term Note Receivable	-	-	-	-	-
Intangible Assets	9.34B	8.99B	8.68B	8.38B	8.1B
Net Goodwill	5.04B	5.04B	5.04B	5.04B	5.1B
Net Other Intangibles	4.3B	3.95B	3.64B	3.34B	3B
Other Assets	230M	295.6M	396.4M	349.1M	362.9M
Tangible Other Assets	230M	295.6M	396.4M	349.1M	362.9M
Total Assets	13.25B	13.58B	13.93B	17.54B	18.1B
Assets - Total - Growth	-	2.49%	2.57%	25.93%	3.18%

Liabilities & Shareholders' Equity

	2016	2017	2018	2019	2020
ST Debt & Current Portion LT Debt	167M	167.4M	343.8M	145.5M	176.1M
Short Term Debt	-	-	250M	18.8M	28.1M
Current Portion of Long Term Debt	167M	167.4M	93.8M	126.7M	148M
Accounts Payable	64M	70.8M	74.4M	74M	118.6M
Accounts Payable Growth	-	10.63%	5.08%	-0.54%	60.27%
Income Tax Payable	-	-	-	-	-
Other Current Liabilities	592M	714.3M	755.8M	974.8M	1.33B
Dividends Payable	-	-	-	-	-
Accrued Payroll	121M	149.9M	170.4M	191.3M	242.3M
Miscellaneous Current Liabilities	471M	564.4M	585.4M	783.5M	1.09B
Total Current Liabilities	823M	952.5M	1.17B	1.19B	1.62B
Long-Term Debt	2.89B	2.72B	2.86B	2.61B	2.66B
Long-Term Debt excl. Capitalized Leases	2.89B	2.72B	2.5B	2.38B	2.42B
Non-Convertible Debt	2.89B	2.72B	2.5B	2.38B	2.42B
Convertible Debt	-	-	-	-	-
Capitalized Lease Obligations	-	-	361M	72.9M	67.3M
Provision for Risks & Charges	129M	168.9M	183.2M	192.4M	299.4M
Deferred Taxes	396M	365M	391.1M	(208.8M)	(567.2M)
Deferred Taxes - Credit	396M	365M	391.1M	2.08B	1.63B
Deferred Taxes - Debit	-	-	-	2.29B	2.2B
Other Liabilities	323M	483.1M	155.6M	192.7M	231.5M
Other Liabilities (excl. Deferred Income)	323M	483.1M	155.6M	192.7M	231.5M
Deferred Income	-	-	-	-	-
Total Liabilities	4.56B	4.69B	4.77B	6.27B	6.45B
Non-Equity Reserves	-	-	-	-	-
Total Liabilities / Total Assets	34.40%	34.53%	34.21%	35.75%	35.64%
Preferred Stock (Carrying Value)	-	-	-	-	-
Redeemable Preferred Stock	-	-	-	-	-
Non-Redeemable Preferred Stock	-	-	-	-	-
Common Equity (Total)	8.69B	8.89B	9.17B	11.27B	11.65B
Common Stock Par/Carry Value	-	-	-	-	-
Retained Earnings	1.82B	2.24B	2.33B	4.64B	5.24B
ESOP Debt Guarantee	-	-	-	-	-
Cumulative Translation Adjustment/Unrealized For. Exch. Gain	(24M)	(15.9M)	(16.4M)	(17.4M)	(11.7M)
Unrealized Gain/Loss Marketable Securities	(1M)	200,000	9.6M	(100,000)	-
Revaluation Reserves	-	-	-	-	-
Treasury Stock	(1.14B)	(1.6B)	(1.69B)	(2.11B)	(2.62B)
Common Equity / Total Assets	65.60%	65.47%	65.79%	64.25%	64.36%
Total Shareholders' Equity	8.69B	8.89B	9.17B	11.27B	11.65B
Total Shareholders' Equity / Total Assets	65.60%	65.47%	65.79%	64.25%	64.36%
Accumulated Minority Interest	-	-	-	-	-
Total Equity	8.69B	8.89B	9.17B	11.27B	11.65B
Liabilities & Shareholders' Equity	13.25B	13.58B	13.93B	17.54B	18.1B

MarketWatch.com

Follow MarketWatch
RSS
Podcasts

Intraday Data provided by FACTSET and subject to terms of use. Historical and current end-of-day data provided by FACTSET. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.

Alexion Pharmaceuticals Inc.

Annual Financials for Alexion Pharmaceuticals Inc.

Assets

Liabilities & Shareholders' Equity

Latest News

dow

nasdaq

s&p 500

Kiosk